Leonard S. Schleifer - 15 May 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
President & CEO, Director
Signature
/s/**Leonard S. Schleifer
Issuer symbol
REGN
Transactions as of
15 May 2023
Net transactions value
$0
Form type
4
Filing time
17 May 2023, 16:10:08 UTC
Previous filing
07 Apr 2022
Next filing
13 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Gift $0 -53,807 -100% $0.000000* 0 15 May 2023 2021 GRAT
transaction REGN Common Stock Gift $0 +53,807 +481% $0.000000 64,985 15 May 2023 By Trust
holding REGN Common Stock 362,115 15 May 2023 Direct
holding REGN Common Stock 250,000 15 May 2023 2023 GRAT
holding REGN Common Stock 5,916 15 May 2023 By 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.